‘Clayface’ Presales Trail ‘Resident Evil’ by a Wide Margin, and DC’s Horror Gamble Faces Some Tricky Math

Every October, a handful of horror releases try to cash in on the Halloween mood, and this year DC Studios wants a seat at the table. ‘Clayface‘, the R-rated body horror from Warner Bros., has been quietly building curiosity as its theatrical date approaches. Early ticket sales are now giving box office watchers their first real clues about how it might open.

The film, directed by James Watkins from a script by Mike Flanagan and Hossein Amini, stars Tom Rhys Harries in the title role. Naomi Ackie, David Dencik, Max Minghella and Eddie Marsan round out the cast, while Matt Reeves, James Gunn and Peter Safran are among the producers. It was originally scheduled for Sept. 11 before Warner Bros. moved it to Oct. 23, though no reason was given for the shift.

The latest data point comes from a Box Office Theory forum post that compares ‘Clayface’ presales at one theater chain to those of ‘Resident Evil’. According to that post, ‘Clayface’ is running 66% behind the horror hit at the same point before release. The poster translated that gap into an opening weekend of roughly $20 million.

That is a useful snapshot, but it comes with caveats. Presales at a single chain capture only part of the audience, and horror crowds are notorious for buying tickets late. The comparison also sets a DC character piece against a record-setting franchise film, which is a very high bar.

Zach Cregger’s ‘Resident Evil’ opened to $60 million domestically, the biggest start in the franchise’s history, and brought in $108.3 million worldwide on its first weekend. Being 66% behind a launch that size still leaves ‘Clayface’ in respectable territory, which is exactly why the math lands near the low end of other forecasts.

In other words, trailing a hit that strong is not the same as trailing a flop. The presales read looks less like a warning sign than a sign of a modest, genre-driven debut.

Long-range tracking from Box Office Pro put the domestic opening at $23 million to $33 million. A separate Box Office Theory projection, shared in September, pointed to $20 million to $26 million. Another report said Box Office Theory expected ‘Clayface’ to open close to the $23.5 million it projected for ‘Digger’.

Seen together, the new presales estimate sits at the bottom of the range, but it is not an outlier. The tracking also suggests that general awareness trails comparable releases, even though interest among people who do know about the film is reportedly above average. That pattern usually signals a smaller but dedicated audience, which fits the profile of a horror release.

The final trailer for DC’s ‘CLAYFACE’ has been released. In theaters on October 23. https://t.co/ecTMB97Sto

— DiscussingFilm (@DiscussingFilm) September 24, 2026

‘Clayface’ reportedly cost about $40 million to make, a modest figure by superhero standards. The usual rule of thumb is that a film needs roughly double its budget to cover marketing and distribution, which puts the break-even point at around $80 million to $100 million worldwide. A domestic opening near $20 million would not guarantee a profit, but it would not rule one out either.

The comparison that looms largest is ‘Supergirl’, which opened to $37.1 million domestically and finished with about $126 million worldwide, a result widely described as disappointing. The bar for ‘Clayface’ is lower, but the studio will still want strong legs once word of mouth kicks in.

The calendar is not entirely friendly. ‘Street Fighter’ arrives the week before on Oct. 16 and is seen as the bigger threat for the top spot, while ‘Klara and the Sun’, ‘Wildwood’ and ‘Wicker’ are among the titles reported to open on the same weekend as ‘Clayface’. A packed field could limit how much room the film has to grow.

There is still time for the picture to change. Reviews and first reactions are expected in the coming weeks, and a strong critical response could lift walk-up sales in a way presales cannot capture. Horror has also been having a good year, with ‘Backrooms’ and ‘Obsession’ cited as signs of a healthy genre market.

For now, the early numbers suggest ‘Clayface’ is headed for a solid but unspectacular start. Whether it can turn that into a lasting run may depend less on opening weekend and more on how audiences respond to DC’s risky horror bet.

Have something to add? Let us know in the comments!